Evidence map›Paper›PMID 36097103›Full record

ArticleNeurochemical research2023

Astrocyte Responses to Complement Peptide C3a are Highly Context-Dependent.

Marcela Pekna, Sumen Siqin, Yolanda de Pablo, Anna Stokowska, Åsa Torinsson Naluai, Milos Pekny

Open access · hybridFull text read
In one paragraph

Article in Neurochemical research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Marcela PeknaLaboratory of Regenerative Neuroimmunology, Department of Clinical Neuroscience, Center for Brain Repair, Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg, Box 440, 405 30, Göteborg, Sweden. marcela.pekna@neuro.gu.se.
Sumen SiqinLaboratory of Regenerative Neuroimmunology, Department of Clinical Neuroscience, Center for Brain Repair, Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg, Box 440, 405 30, Göteborg, Sweden.
Yolanda de PabloLaboratory of Astrocyte Biology and CNS Regeneration, Department of Clinical Neuroscience, Center for Brain Repair, Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg, Box 440, 405 30, Göteborg, Sweden.
Anna StokowskaLaboratory of Regenerative Neuroimmunology, Department of Clinical Neuroscience, Center for Brain Repair, Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg, Box 440, 405 30, Göteborg, Sweden.
Åsa Torinsson NaluaiDepartment of Laboratory Medicine, Institute of Biomedicine, Sahlgrenska Academy at the University of Gothenburg, Göteborg, Sweden.
Milos PeknyLaboratory of Astrocyte Biology and CNS Regeneration, Department of Clinical Neuroscience, Center for Brain Repair, Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg, Box 440, 405 30, Göteborg, Sweden. milos.pekny@neuro.gu.se.
University of Gothenburg · SEFlorey Institute of Neuroscience and Mental Health · AU

Funding

Hjärnfonden FO2017-0004Hjärnfonden FO2018-0252Hjärnfonden FO2020-0134Hjärnfonden FO2021-0082The Swedish state under the agreement between the Swedish government and the county councils, the ALF agreement 716591The Swedish state under the agreement between the Swedish government and the county councils, the ALF agreement 724421The Swedish state under the agreement between the Swedish government and the county councils, the ALF agreement 965939The Swedish state under the agreement between the Swedish government and the county councils, the ALF agreement 966011Vetenskapsrådet 2017-00991Vetenskapsrådet 2017-02255Vetenskapsrådet 2019-00284Vetenskapsrådet 2020-01148Vetenskapsrådet 2021-01486
6 · The paper itself

Abstract

Astrocytes perform a range of homeostatic and regulatory tasks that are critical for normal functioning of the central nervous system. In response to an injury or disease, astrocytes undergo a pronounced transformation into a reactive state that involves changes in the expression of many genes and dramatically changes astrocyte morphology and functions. This astrocyte reactivity is highly dependent on the initiating insult and pathological context. C3a is a peptide generated by the proteolytic cleavage of the third complement component. C3a has been shown to exert neuroprotective effects, stimulate neural plasticity and promote astrocyte survival but can also contribute to synapse loss, Alzheimer's disease type neurodegeneration and blood-brain barrier dysfunction. To test the hypothesis that C3a elicits differential effects on astrocytes depending on their reactivity state, we measured the expression of Gfap, Nes, C3ar1, C3, Ngf, Tnf and Il1b in primary mouse cortical astrocytes after chemical ischemia, after exposure to lipopolysaccharide (LPS) as well as in control naïve astrocytes. We found that C3a down-regulated the expression of Gfap, C3 and Nes in astrocytes after ischemia. Further, C3a increased the expression of Tnf and Il1b in naive astrocytes and the expression of Nes in astrocytes exposed to LPS but did not affect the expression of C3ar1 or Ngf. Jointly, these results provide the first evidence that the complement peptide C3a modulates the responses of astrocytes in a highly context-dependent manner.

Indexed as

AstrocytesLipopolysaccharidesAnimalsBlood-Brain BarrierComplement C3aMicePeptidesComplement C3aLipopolysaccharidesPeptidesGene expressionGliaIschemiaLipopolysaccharideNeurodegeneration

Identifiers

PMID36097103
PMCPMC10030406
OpenAlexW4295309503

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read23
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.